Risk factors for treatment outcome in fungal keratitis. 2006

Prajna Lalitha, and Namperumalsamy Venkatesh Prajna, and Amit Kabra, and Kannan Mahadevan, and Muthaiah Srinivasan
Department of Ocular Microbiology, Aravind Eye Hospital and PG Institute of Ophthalmology, Madurai, Tamilnadu, India. lalitha@aravind.org

OBJECTIVE To identify risk factors at diagnosis that can serve as prognostic indicators of primary treatment failure in cases of fungal keratitis. METHODS Prospective, nonrandomized, interventional, comparative study. METHODS A total of 115 consecutive patients with fungal keratitis treated at one center during a 6-month period. METHODS Patients with a microscopic corneal ulcer smear that was positive for fungus were enrolled and treated with 5% natamycin monotherapy according to the protocol of the hospital. Treatment responses were assessed at the end of 4 weeks. The prognostic indicators were used in a Poisson model for multiple regression analysis to estimate the relative risk of the main prognostic variables. METHODS Response of the ulcer to treatment. RESULTS Of the 115 patients analyzed in the study, 52 (45.2%) were treatment successes, 27 (23.5%) had slow-healing ulcers, and 36 (31.3%) were refractory to primary treatment. Multivariate analysis showed that the predictors of treatment failure were ulcers that exceeded 14 mm(2) (P = 0.009), the presence of hypopyon (P = 0.003), and identification of Aspergillus (P = 0.003). CONCLUSIONS In patients with fungal keratitis treated with 5% natamycin monotherapy, larger ulcer size and infection with Aspergillus were predictors of a poor outcome.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009181 Mycoses Diseases caused by FUNGI. Fungus Diseases,Fungal Diseases,Fungal Infections,Fungus Infections,Disease, Fungal,Disease, Fungus,Diseases, Fungal,Diseases, Fungus,Fungal Disease,Fungal Infection,Fungus Disease,Fungus Infection,Infection, Fungal,Infection, Fungus,Infections, Fungal,Infections, Fungus
D010866 Natamycin Amphoteric macrolide antifungal antibiotic from Streptomyces natalensis or S. chattanoogensis. It is used for a variety of fungal infections, mainly topically. Pimaricin,Tennecetin,Myprozine,Pimafucin
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003320 Corneal Ulcer Loss of epithelial tissue from the surface of the cornea due to progressive erosion and necrosis of the tissue; usually caused by bacterial, fungal, or viral infection. Keratitis, Ulcerative,Keratitides, Ulcerative,Ulcer, Corneal,Ulcerative Keratitides,Ulcerative Keratitis
D005260 Female Females
D005658 Fungi A kingdom of eukaryotic, heterotrophic organisms that live parasitically as saprobes, including MUSHROOMS; YEASTS; smuts, molds, etc. They reproduce either sexually or asexually, and have life cycles that range from simple to complex. Filamentous fungi, commonly known as molds, refer to those that grow as multicellular colonies. Fungi, Filamentous,Molds,Filamentous Fungi,Filamentous Fungus,Fungus,Fungus, Filamentous,Mold

Related Publications

Prajna Lalitha, and Namperumalsamy Venkatesh Prajna, and Amit Kabra, and Kannan Mahadevan, and Muthaiah Srinivasan
March 2007, Ophthalmology,
Prajna Lalitha, and Namperumalsamy Venkatesh Prajna, and Amit Kabra, and Kannan Mahadevan, and Muthaiah Srinivasan
September 2022, Journal of fungi (Basel, Switzerland),
Prajna Lalitha, and Namperumalsamy Venkatesh Prajna, and Amit Kabra, and Kannan Mahadevan, and Muthaiah Srinivasan
November 2015, American journal of ophthalmology,
Prajna Lalitha, and Namperumalsamy Venkatesh Prajna, and Amit Kabra, and Kannan Mahadevan, and Muthaiah Srinivasan
July 2009, Cornea,
Prajna Lalitha, and Namperumalsamy Venkatesh Prajna, and Amit Kabra, and Kannan Mahadevan, and Muthaiah Srinivasan
December 2016, Mycopathologia,
Prajna Lalitha, and Namperumalsamy Venkatesh Prajna, and Amit Kabra, and Kannan Mahadevan, and Muthaiah Srinivasan
December 1995, The British journal of ophthalmology,
Prajna Lalitha, and Namperumalsamy Venkatesh Prajna, and Amit Kabra, and Kannan Mahadevan, and Muthaiah Srinivasan
August 1996, The British journal of ophthalmology,
Prajna Lalitha, and Namperumalsamy Venkatesh Prajna, and Amit Kabra, and Kannan Mahadevan, and Muthaiah Srinivasan
September 1999, The British journal of ophthalmology,
Prajna Lalitha, and Namperumalsamy Venkatesh Prajna, and Amit Kabra, and Kannan Mahadevan, and Muthaiah Srinivasan
September 2012, Eye (London, England),
Prajna Lalitha, and Namperumalsamy Venkatesh Prajna, and Amit Kabra, and Kannan Mahadevan, and Muthaiah Srinivasan
June 2019, Retina (Philadelphia, Pa.),
Copied contents to your clipboard!